Literature DB >> 19193352

Toxic psychosis after intake of the hallucinogen salvinorin A.

Michael Paulzen, Gerhard Gründer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19193352     DOI: 10.4088/jcp.v69n0919c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  9 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.

Authors:  Mohini Ranganathan; Ashley Schnakenberg; Patrick D Skosnik; Bruce M Cohen; Brian Pittman; R Andrew Sewell; Deepak Cyril D'Souza
Journal:  Biol Psychiatry       Date:  2012-07-18       Impact factor: 13.382

3.  Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.

Authors:  Ryan Vandrey; Matthew W Johnson; Patrick S Johnson; Miral A Khalil
Journal:  Adolesc Psychiatry (Hilversum)       Date:  2013-04

4.  The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.

Authors:  Hugo A Tejeda; Vladimir I Chefer; Agustin Zapata; Toni S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

5.  Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.

Authors:  Matthew W Johnson; Katherine A MacLean; Chad J Reissig; Thomas E Prisinzano; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2010-12-04       Impact factor: 4.492

6.  Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.

Authors:  Katherine A MacLean; Matthew W Johnson; Chad J Reissig; Thomas E Prisinzano; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2012-11-08       Impact factor: 4.530

7.  Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial.

Authors:  John E Mendelson; Jeremy R Coyle; Juan Carlos Lopez; Matthew J Baggott; Keith Flower; E Thomas Everhart; Thomas A Munro; Gantt P Galloway; Bruce M Cohen
Journal:  Psychopharmacology (Berl)       Date:  2010-12-08       Impact factor: 4.530

Review 8.  Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects.

Authors:  Andreia Machado Brito-da-Costa; Diana Dias-da-Silva; Nelson G M Gomes; Ricardo Jorge Dinis-Oliveira; Áurea Madureira-Carvalho
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-03

9.  Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan.

Authors:  Po-Xiang Lin; Jih-Heng Li; Su-Hwei Chen; Hsien-Chang Chang; Rebecca McKetin
Journal:  J Food Drug Anal       Date:  2014-02-16       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.